Moderna’s COVID-19 Vaccine Granted Full Approval by US FDA: Report

Moderna's COVID-19 vaccine has received full approval from the US Food and Drug Administration (FDA).

The vaccine, named Spikevax, is approved for use in people aged 18 and older, Xinhua news agency reported.

Spikevax meets the FDA's rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.

"While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated."

Janet Woodcock, Acting FDA Commissioner

"Today's milestone puts us one step closer to altering the course of this pandemic in the US," she said.

Moderna's COVID-19 vaccine is the second one in the US to receive full approval from the FDA.

Pfizer's COVID-19 vaccine, Comirnaty, was fully approved for use in people ages 16 and older in August 2021.

Moderna's COVID-19 vaccine has been available under the FDA's emergency use authorization for individuals 18 years of age and older since 18 December, 2020.

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT.)

(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)

Access to all paywalled content on site
Ad-free experience across The Quint
Early previews of our Special Projects

And more membership benefits!

Continue

Published: undefined

SCROLL FOR NEXT